Skip to main content
Advertisement
Advertisement

PMVP

PMVP logo

PMV Pharmaceuticals, Inc

1.37
USD
Sponsored
-0.14
-9.27%
Sep 23, 16:00 UTC -4
Closed
exchange

After-Market

1.38

0.00
+0.36%

PMVP Earnings Reports

Positive Surprise Ratio

PMVP beat 15 of 23 last estimates.

65%

Next Report

Date of Next Report
Nov 10, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
-$0.34
Implied change from Q2 26 (Revenue/ EPS)
--
/
--
Implied change from Q3 25 (Revenue/ EPS)
--
/
-15.00%

PMV Pharmaceuticals, Inc earnings per share and revenue

On Aug 14, 2026, PMVP reported earnings of -0.34 USD per share (EPS) for Q2 26, beating the estimate of -0.39 USD, resulting in a 13.99% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +3.70% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 5 analysts forecast an EPS of -0.34 USD, with revenue projected to reach -- USD, implying an increase of 0.00% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Champions Oncology, Inc.
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.01
Actual
-$0.03
Surprise
-194.12%
logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
FAQ
For Q2 2026, PMV Pharmaceuticals, Inc reported EPS of -$0.34, beating estimates by 13.99%, and revenue of $0.00, 0% as expectations.
The stock price moved up 3.7%, changed from $1.22 before the earnings release to $1.26 the day after.
The next earning report is scheduled for Nov 10, 2026.
Based on 5 analysts, PMV Pharmaceuticals, Inc is expected to report EPS of -$0.34 and revenue of -- for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement